Long-term entecavir therapy reverses fibrosis and cirrhosis in chronic hepatitis B patients
Wednesday, August 18, 2010 - 21:14
in Health & Medicine
Researchers have found that patients with chronic hepatitis B virus (HBV) infection who received at least 3 years of cumulative entecavir (antiviral) therapy achieved substantial histologic improvement and regression of fibrosis or cirrhosis.